Description
A local research facility is seeking participants for a clinical research study on Ulcerative Colitis. The purpose of this clinical study is to see how effective an investigational medication is at helping to treat adults with moderately to severely active Ulcerative Colitis (UC). The study medication is currently FDA-approved to treat several inflammatory conditions and is being explored as a new therapy option for UC patients.
Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated for time and travel.
Space is limited, subject to availability. Criteria for qualification are subject to change at any time and without notice.